Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Deficiency - Summary of Options Activity (Details)

v3.5.0.2
Stockholders' Deficiency - Summary of Options Activity (Details)
9 Months Ended
Sep. 30, 2016
USD ($)
$ / shares
shares
Equity [Abstract]  
Number of shares options outstanding | shares 7,781,667
Number of shares options granted | shares 130,000
Number of shares options exercised | shares
Number of shares options canceled/forfeited/expired | shares (988,332)
Number of shares options outstanding | shares 6,923,335
Number of shares options exercisable | shares 6,041,001
Weighted average exercise price options outstanding | $ / shares $ 1.15
Weighted average exercise price options granted | $ / shares 0.38
Weighted average exercise price options exercised | $ / shares
Weighted average exercise price options canceled/forfeited/expired | $ / shares 1.11
Weighted average exercise price options outstanding | $ / shares 1.14
Weighted average exercise price option exercisable | $ / shares $ 1.19
Weighted average remaining life in years outstanding 2 years 3 months 18 days
Weighted average remaining life in years exercisable 2 years 1 month 6 days
Aggregate intrinsic value outstanding | $ $ 27,900
Aggregate intrinsic value exercisable | $ $ 27,900